<DOC>
	<DOC>NCT01745549</DOC>
	<brief_summary>During the last years, even more little needles are used for the injection of sub cutaneous insulin, for the diabetes therapy. The aim of this study is to evaluate the non inferiority of a new needle, smaller than another needle, in terms of hematic levels od fructosamine, an indicator of glycemic control.</brief_summary>
	<brief_title>Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm.</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>patients with type 1 or type 2 diabetes both males and females age &gt;=18 anni insulin treatment from at least 6 months signed informed consent pregnancy incapacity for filling in the questionnaires every illness or condition that, according to the investigator, could interfere with the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>diabetes</keyword>
	<keyword>insulin therapy</keyword>
	<keyword>needle</keyword>
</DOC>